Evidence map›Paper›PMID 33371881›Full record

ArticleBMC bioinformatics2020

The shape of gene expression distributions matter: how incorporating distribution shape improves the interpretation of cancer transcriptomic data.

Laurence de Torrenté, Samuel Zimmerman, Masako Suzuki, Maximilian Christopeit, John M Greally, Jessica C Mar

Abstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Understanding Iron and Oxidative Stress Response inbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laurence de TorrentéDepartment of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Samuel ZimmermanDepartment of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Masako SuzukiCenter for Epigenomics and Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Maximilian ChristopeitInternal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Otfried-Mueller-Strasse 10, 72076, Tuebingen, Germany.
John M GreallyCenter for Epigenomics and Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
Jessica C MarDepartment of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA. j.mar@uq.edu.au.

Funding

UNDERSTANDING CELLULAR AND TRANSCRIPTIONAL REGULATORY CHANGES IN HUMAN AGINGR01AG057422 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GREALLY, JOHN, LAPPALAINEN, TUULI · 2018 to 2022
$4.5M
Australian Research Council Future Fellowship FT170100047National Stem Cell Foundation of Australia Metcalf PrizeNIA NIH HHS R01 AG057422
6 · The paper itself

Abstract

backgroundIn genomics, we often assume that continuous data, such as gene expression, follow a specific kind of distribution. However we rarely stop to question the validity of this assumption, or consider how broadly applicable it may be to all genes that are in the transcriptome. Our study investigated the prevalence of a range of gene expression distributions in three different tumor types from the Cancer Genome Atlas (TCGA).

resultsSurprisingly, the expression of less than 50% of all genes was Normally-distributed, with other distributions including Gamma, Bimodal, Cauchy, and Lognormal also represented. Most of the distribution categories contained genes that were significantly enriched for unique biological processes. Different assumptions based on the shape of the expression profile were used to identify genes that could discriminate between patients with good versus poor survival. The prognostic marker genes that were identified when the shape of the distribution was accounted for reflected functional insights into cancer biology that were not observed when standard assumptions were applied. We showed that when multiple types of distributions were permitted, i.e. the shape of the expression profile was used, the statistical classifiers had greater predictive accuracy for determining the prognosis of a patient versus those that assumed only one type of gene expression distribution.

conclusionsOur results highlight the value of studying a gene's distribution shape to model heterogeneity of transcriptomic data and the impact on using analyses that permit more than one type of gene expression distribution. These insights would have been overlooked when using standard approaches that assume all genes follow the same type of distribution in a patient cohort.

Indexed as

Data Interpretation, StatisticalGene Expression ProfilingBiomarkers, TumorGenomicsHumansMaleMiddle AgedNeoplasmsPrognosisBiomarkers, TumorCancer genomicsGene expressionMulti-modalityNon-normal distributionSurvival analysis

Identifiers

PMID33371881
PMCPMC7768656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.